PRESS RELEASE published on 04/18/2024 at 13:27, 1 year 9 months ago Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments Evotec SE and Variant Bio partner to discover and develop fibrosis treatments, leveraging cutting-edge genomic discovery platforms. Agreement includes research funding and milestone/royalty payments Evotec SE Research Funding Variant Bio Genomic Discovery Fibrosis Treatments
BRIEF published on 04/17/2024 at 15:05, 1 year 9 months ago Evotec SE Set to Announce 2023 Fiscal Year Results Financial Results Life Sciences Evotec SE Fiscal Year 2023 Stakeholder Engagement
BRIEF published on 04/17/2024 at 15:05, 1 year 9 months ago Evotec SE s'apprête à annoncer ses résultats pour l'exercice 2023 Résultats Financiers Evotec SE Exercice 2023 Sciences De La Vie Engagement Des Parties Prenantes
PRESS RELEASE published on 04/17/2024 at 15:00, 1 year 9 months ago Evotec SE to announce results for fiscal year 2023 on 24 April 2024 Evotec SE will announce its financial results for 2023 with a conference call on 24 April 2024. The company focuses on developing therapeutics through a unique business model Financial Results Conference Call Evotec SE Therapeutics Business Model
BRIEF published on 04/17/2024 at 07:35, 1 year 9 months ago Evotec Appoints Aurélie Dalbiez as Chief People Officer Chief People Officer Human Resources Corporate Leadership Evotec Aurélie Dalbiez
BRIEF published on 04/17/2024 at 07:35, 1 year 9 months ago Evotec nomme Aurélie Dalbiez au poste de Chief People Officer Ressources Humaines Evotec Direction D'entreprise Aurélie Dalbiez Directeur Des Ressources Humaines
PRESS RELEASE published on 04/17/2024 at 07:30, 1 year 9 months ago Evotec welcomes Aurélie Dalbiez as Chief People Officer Evotec SE appoints Aurélie Dalbiez as Chief People Officer, bringing extensive HR leadership experience to drive organizational transformation and employee engagement Chief People Officer Evotec SE Human Resources Aurélie Dalbiez Organizational Transformation
BRIEF published on 03/06/2024 at 07:35, 1 year 11 months ago Evotec and Claris Ventures Partner to Accelerate Biotech Clinical Programs Evotec SE Claris Ventures Biotech Clinical Development IAMA Therapeutics Drug Development Partnership
BRIEF published on 03/06/2024 at 07:35, 1 year 11 months ago Evotec et Claris Ventures s'associent pour accélérer les programmes cliniques de biotechnologie Evotec SE Claris Ventures Développement Clinique Biotechnologique IAMA Thérapeutique Partenariat Pour Le Développement De Médicaments
PRESS RELEASE published on 03/06/2024 at 07:30, 1 year 11 months ago Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic. Evotec and Claris announce acceleration framework to support biotech companies with clinical trials Clinical Trials Claris Ventures Evotec Acceleration Framework Biotech Companies
Published on 02/06/2026 at 08:00, 4 hours 19 minutes ago Caledonia Mining Corporation Plc Non-Executive Director Shareholding Notification
Published on 02/06/2026 at 03:50, 8 hours 29 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 02:45, 9 hours 34 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 00:57, 11 hours 22 minutes ago Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 12 hours 19 minutes ago LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/06/2026 at 11:45, 33 minutes ago Le Conseil d’administration de Sartorius Stedim Biotech S.A. approuve une proposition de dividende de 0,69 euro
Published on 02/06/2026 at 11:45, 33 minutes ago Board of Directors of Sartorius Stedim Biotech S.A. resolves dividend proposal of 0.69 euros
Published on 02/06/2026 at 11:43, 36 minutes ago The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share
Published on 02/06/2026 at 11:26, 53 minutes ago CTS EVENTIM: Successful Olympic Premiere for New Arena in Milano
Published on 02/06/2026 at 07:54, 4 hours 24 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
Published on 02/05/2026 at 19:15, 17 hours 4 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 17 hours 4 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026